Data Year:

For its 2024 fiscal year, ADAPTHEALTH CORP, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In Retail & Wholesale industry
Joshua Parnes
Former President
Total Compensation $10,441,920 View details Pay Rank By Title In Retail & Wholesale industry #1 View more
Richard Barasch
Former Interim Chief Executive Officer, Director
Total Compensation $2,074,106 View details Pay Rank By Title In Retail & Wholesale industry #182 View more
Shaw Rietkerk
Former Chief Operating Officer
Total Compensation $2,384,126 View details Pay Rank By Title In Retail & Wholesale industry #38 View more
Jason Clemens
Chief Financial Officer
Total Compensation $6,352,226 View details Pay Rank By Title In Retail & Wholesale industry #14 View more
Albert Prast
Chief Technology Officer
Total Compensation $2,852,105 View details Pay Rank By Title In Retail & Wholesale industry #4 View more
Christine Archbold
Chief Accounting Officer
Total Compensation $1,355,749 View details Pay Rank By Title In Retail & Wholesale industry #5 View more
Toby Scott Barnhart
Chief Operating Officer
Total Compensation $1,347,142 View details Pay Rank By Title In Retail & Wholesale industry #55 View more
Suzanne Foster
Chief Executive Officer
Total Compensation $8,391,752 View details Pay Rank By Title In Retail & Wholesale industry #79 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at ADAPTHEALTH CORP as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. ADAPTHEALTH CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. ADAPTHEALTH CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Joshua Parnes
Former President
Total Cash $420,673 Equity $7,025,696 Other $2,995,551 $10,441,920
Richard Barasch
Former Interim Chief Executive Officer, Director
Total Cash $1,235,402 Equity $474,408 Other $364,296 $2,074,106
Shaw Rietkerk
Former Chief Operating Officer
Total Cash $499,856 Equity $1,882,494 Other $1,776 $2,384,126
Jason Clemens
Chief Financial Officer
Total Cash $1,380,144 Equity $4,949,552 Other $22,530 $6,352,226
Albert Prast
Chief Technology Officer
Total Cash $968,819 Equity $1,882,494 Other $792 $2,852,105
Christine Archbold
Chief Accounting Officer
Total Cash $593,299 Equity $753,008 Other $9,442 $1,355,749
Toby Scott Barnhart
Chief Operating Officer
Total Cash $353,898 Equity $993,145 Other $99 $1,347,142
Suzanne Foster
Chief Executive Officer
Total Cash $1,798,434 Equity $6,592,784 Other $534 $8,391,752
For its 2024 fiscal year, ADAPTHEALTH CORP, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Suzanne Foster CEO Pay $8,730,506 Median Employee Pay $50,869 CEO Pay Ratio 172:1
For its 2024 fiscal year, ADAPTHEALTH CORP, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Bradley Coppens Total Cash $298,034
Dale Wolf Total Cash $395,026
David S. Williams, III Total Cash $285,458
Diana Nole Total Cash $148,650
Greg Belinfanti Total Cash $278,791
Susan Weaver, M.D. Total Cash $282,124
Ted Lundberg Total Cash $303,694
Terence Connors Total Cash $308,791
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.